Yttrium-90 radioembolization as a bridge to liver transplantation: A single-institution experience

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 11, 2013, Pages 1632-1638

  Tohme, Samer ^a   Sukato, Daniel ^a   Chen, Hui Wei ^a   Amesur, Nikhil ^b   Zajko, Albert B ^b   Humar, Abhinav ^a   Geller, David A ^a   Marsh, James W ^a   Tsung, Allan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; YTTRIUM 90;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DEVICES; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR NECROSIS;

HCC; HEPATOCELLULAR CARCINOMA; UNITED NETWORK FOR ORGAN SHARING, YTTRIUM-90 = (90)Y; UNOS;

AGED; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS; YTTRIUM RADIOISOTOPES;

EID: 84886864675     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.07.026     Document Type: Article

References (21)

1. F.X. Bosch, J. Ribes, M. Diaz, and R. Cleries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 suppl 2004 S5 S16
2. N. Bhala, P. Angulo, and D. van der Poorten The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study Hepatology 54 2011 1208 1216
3. A.B. Siegel, and A.X. Zhu Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link Cancer 115 2009 5651 5661
4. S.K. Reddy, J.L. Steel, and H.W. Chen Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease Hepatology 55 2012 1809 1819
5. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
6. Health Resources and Services Administration (HRSA - U.S. Department of Health) and Organ Procurement and Transplantation Network (OPTN). UNOS/OPTN Policy 3.6.4.4. Available at: http://optn.transplant.hrsa.gov/ PoliciesandBylaws2/policies/pdfs/policy-8.pdf. Accessed July 1, 2013.
7. R.B. Freeman, E.B. Edwards, and A.M. Harper Waiting list removal rates among patients with chronic and malignant liver diseases Am J Transpl 6 2006 1416 1421
8. F.Y. Yao, N.M. Bass, and B. Nikolai Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873 883
9. F.Y. Yao, L. Ferrell, and N.M. Bass Liver Transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
10. V. Mazzaferro, Y.S. Chun, and R.T. Poon Liver transplantation for hepatocellular carcinoma Ann Surg Oncol 15 2008 1001 1007
11. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
12. R. Salem, V. Mazzaferro, and B. Sangro Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges and clinical perspectives Hepatology 2013 10.1002/hep.26382
13. F. Xie, J. Zang, and X. Guo Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis J Cancer Res Clin Oncol 138 2012 455 462
14. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transpl 9 2009 1920 1928
15. L.M. Kulik, B. Atassi, and L. van Holsbeeck Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586
16. B.I. Carr Hepatic arterial 90Yttrium glass microspheres (TheraSpheres) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients Liver Transpl 10 suppl 2004 S107 S110
17. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
18. A. Riaz, R.J. Lewandowski, L. Kulik, and R.K. Ryu Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization Cardiovasc Intervent Radiol 33 2010 1143 1152
19. A. Obed, A. Beham, K. Pullmann, H. Becker, H.J. Schlitt, and T. Lorf Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation World J Gastroenterol 13 2007 761 767
20. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267
21. D. Seehofer, M. Nebrig, and T. Denecke Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis Clin Transpl 26 2012 764 774